Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Recruiting · NCT06762002 · Registry updated 2026-09-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort | COVID-19, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, allergic disease, hereditary disease, immune system disorder, infectious disease, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-09-18 | NCT06762002 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 219 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cic Bichat | Paris | France | 1 |
| Cic Creteil | Paris | France | 1 |
| Cic La Salpetriere | Paris | France | 1 |
| Cic Lille | Lille | France | 1 |
| Cic Montpellier | Montpellier | France | 1 |
| Cic Necker | Paris | France | 1 |
| Cic St Louis | Paris | France | 1 |
| Cic Tours | Tours | France | 1 |
| LYON HCL | Lyon | France | 1 |